Clinical trials - Press Releases

Date	Title	Company
06-Dec-2020	MAGROLIMAB DEMONSTRATES CLINICAL RESPONSES IN ONGOING PHASE 1B TRIAL OF PREVIOUSLY UNTREATED ACUTE MYELOID LEUKAEMIA PATIENTS	Gilead Sciences, Inc.
06-Dec-2020	NEW FOUR-YEAR DATA SHOW LONG-TERM SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA TREATED WITH YESCARTA® (AXICABTAGENE CILOLEUCEL) IN ZUMA-1 TRIAL	Kite, A Gilead Company
06-Dec-2020	YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY	Kite, A Gilead Company
02-Dec-2020	UK biotech company ILC Therapeutics announces first international investment	ILC Therapeutics
02-Dec-2020	Kallik becomes first artwork and labelling management software company to offer customers the security of Amazon Web Services	Kallik
02-Dec-2020	John Bell & Croyden expands same day coronavirus testing service with launch of new 15-minute point-of-care test	John Bell & Croyden
02-Dec-2020	Actimed Therapeutics Granted Broad US Patent Covering Rights to ACM–002 (S-oxprenolol) for Treating Cancer Cachexia	Actimed Therapeutics
02-Dec-2020	Helsinn and Kyowa Kirin Asia Pacific sign exclusive license and distribution agreement to strengthen their presence in Asia Pacific’s rare disease therapy area	Helsinn Group
02-Dec-2020	Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio	Sosei Group Corporation
02-Dec-2020	Tiziana Life Sciences to Host Investor Update Call on 2 December 2020 at 4:15 p.m. ET	Tiziana Life Sciences plc
02-Dec-2020	Teckro Expands Product Portfolio to Unblock Clinical Research Site Staff	Teckro
02-Dec-2020	UK HEALTHTECH START-UP CERA REACHES $120M REVENUE RUN-RATE IN LESS THAN FOUR YEARS, CONFIRMS 5,000 NEW ROLES NATIONWIDE	Cera
02-Dec-2020	UK set to take advanced therapies and vaccine manufacturing industry to the next level: the Advanced Therapy Skills Training Network launches today – driven by industry and coordinated by the Cell and Gene Therapy Catapult	Cell and Gene Therapy Catapult
02-Dec-2020	Resolution Therapeutics Announces a £26.6m Series A Financing from Syncona Ltd	Resolution Therapeutics Limited
02-Dec-2020	Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships	Boehringer Ingelheim
02-Dec-2020	iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence	iRhythm Technologies, Inc.
02-Dec-2020	A special needle that helps vaccinate millions more against COVID-19	TSK Laboratory
02-Dec-2020	uMed raises £3.7m in venture capital funding to help healthcare providers participate in more clinical studies	uMed
02-Dec-2020	GBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United States	Global Blood Therapeutics, Inc.
02-Dec-2020	UK’s largest ever NHS rare disease diagnosis programme launched by Mendelian and Modality NHS Partnership	Mendelian